These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
237 related items for PubMed ID: 20554347
1. Treatment of angiotensin-converting enzyme inhibitor-related angioedema with the bradykinin B2 receptor antagonist icatibant. Schmidt PW, Hirschl MM, Trautinger F. J Am Acad Dermatol; 2010 Nov; 63(5):913-4. PubMed ID: 20554347 [No Abstract] [Full Text] [Related]
2. [Icatibant is a new treatment option in life-threatening angioedema triggered by angiotensin-converting enzyme inhibitor]. Fast S, Henningsen E, Bygum A. Ugeskr Laeger; 2011 Oct 10; 173(41):2574-5. PubMed ID: 21985837 [Abstract] [Full Text] [Related]
3. Bradykinin-receptor antagonist icatibant: possible treatment for ACE inhibitor-related angio-oedema. Manders K, van Deuren M, Hoedemaekers C, Simon A. Neth J Med; 2012 Oct 10; 70(8):386-7. PubMed ID: 23065991 [No Abstract] [Full Text] [Related]
5. Icatibant: a novel approach to the treatment of angioedema related to the use of angiotensin-converting enzyme inhibitors. Gallitelli M, Alzetta M. Am J Emerg Med; 2012 Oct 10; 30(8):1664.e1-2. PubMed ID: 22100478 [Abstract] [Full Text] [Related]
15. Treatment of acute edema attacks in hereditary angioedema with a bradykinin receptor-2 antagonist (Icatibant). Bork K, Frank J, Grundt B, Schlattmann P, Nussberger J, Kreuz W. J Allergy Clin Immunol; 2007 Jun 30; 119(6):1497-503. PubMed ID: 17418383 [Abstract] [Full Text] [Related]
16. Angiotensin-converting enzyme inhibitor-induced angioedema and icatibant: a new hope. Jacob J, Bardes I, Palom X, Carrizosa M, Fuentes E. Intern Med J; 2015 Oct 30; 45(10):1093-4. PubMed ID: 26429224 [No Abstract] [Full Text] [Related]